Data as of November 21, 2026

Adderall 5 mg Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE

Brand: Adderall

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$466.18/ fill$12.20 / EA
VA Big4
$265.72/ fill$6.96 / EA
FUL
$13.17/ fill$0.34 / EA
AMP
$7.15/ fill$0.19 / EA
Medicaid FFS
$237.51/ fill
Medicaid MCO
$386.67/ fill

Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (38.2 units/fill)$466.18
Dispensing fee & other (state-fixed, not margin)-$228.67
Total reimbursed per fill$237.51

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 5 fee-for-service states, 6 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-11-11; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology